• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Objective, Quantitative, Data-Driven Assessment of Chemical Probes

19 de December de 2017
Cell Chem Biol. 2018 Feb 15;25(2):194-205.e5. doi: 10.1016/j.chembiol.2017.11.004.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-12-19 11:00:002017-12-19 11:00:00Objective, Quantitative, Data-Driven Assessment of Chemical Probes

Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity

17 de December de 2017
Oncotarget. 2017 Oct 15;8(59):99223-99236. doi: 10.18632/oncotarget.21834.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-12-17 11:00:002017-12-17 11:00:00Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

18 de November de 2017
Ann Oncol. 2018 Feb 1;29(2):439-444. doi: 10.1093/annonc/mdx737.ABSTRACTBACKGROUND:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-18 11:00:002017-11-18 11:00:00Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination

18 de November de 2017
Mol Cancer Ther. 2018 Feb;17(2):532-543. doi: 10.1158/1535-7163.MCT-17-0643.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-18 11:00:002017-11-18 11:00:00A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination

18 de November de 2017
Mol Cancer Ther. 2018 Feb;17(2):532-543. doi: 10.1158/1535-7163.MCT-17-0643.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-18 11:00:002017-11-18 11:00:00A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination

Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study

17 de November de 2017
Int J Mol Sci. 2017 Oct 28;18(11):2263. doi: 10.3390/ijms18112263.ABSTRACTPrevention…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-17 11:00:002017-11-17 11:00:00Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

11 de November de 2017
Br J Cancer. 2017 Dec 5;117(12):1777-1786. doi: 10.1038/bjc.2017.279.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-11 11:00:002017-11-11 11:00:00Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program

2 de November de 2017
Oncotarget. 2017 Jun 3;8(43):73640-73653. doi: 10.18632/oncotarget.18363.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-11-02 10:00:002017-11-02 10:00:00Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program

Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism

24 de October de 2017
Oncogene. 2018 Feb 15;37(7):963-970. doi: 10.1038/onc.2017.367.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-10-24 10:00:002017-10-24 10:00:00Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

24 de October de 2017
Nat Genet. 2017 Dec;49(12):1767-1778. doi: 10.1038/ng.3785. Epub…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-10-24 10:00:002017-10-24 10:00:00Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A

11 de October de 2017
Mol Cancer Res. 2018 Jan;16(1):16-31. doi: 10.1158/1541-7786.MCR-17-0417.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-10-11 10:00:002017-10-11 10:00:00Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A

Load-dependent surface diffusion model for analyzing the kinetics of protein adsorption onto mesoporous materials

2 de October de 2017
J Colloid Interface Sci. 2018 Feb 1;511:27-38. doi: 10.1016/j.jcis.2017.09.091.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-10-02 10:00:002017-10-02 10:00:00Load-dependent surface diffusion model for analyzing the kinetics of protein adsorption onto mesoporous materials
Page 60 of 87«‹5859606162›»

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (8)
  • Sureda's & Farre's Lab (312)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}